Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Exercise/Conversion of 1 APVO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 1 | n/a |
| May 4, 2026 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 25,344 | n/a |
| Aug 8, 2025 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 30,000 | n/a |
| Jul 21, 2025 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 10 | n/a |
| May 3, 2025 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 34,403 | n/a |
| Mar 4, 2025 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 8 | n/a |
| Nov 13, 2024 | Emergent BioSolutions Inc. (EBS) | Sale | 14,287 | $171.0K |
| Jul 19, 2024 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 22,325 | n/a |
| May 29, 2024 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 17,430 | n/a |
| Mar 5, 2024 | Aptevo Therapeutics Inc. (APVO) | Exercise/Conversion | 12,917 | n/a |